In a recent paper discussing particle counting and analytical techniques, the number and type of particles present in intravitreal injection …
Read Post
The team at the University of Colorado, Boulder have long been FlowCam customers, most recently incorporating FlowCam images with artificial …
Read Post
West Pharmaceutical Laboratories (Exton, PA) recently published a paper on a streamlined bioanalytical approach to determine the most appropriate …
Read Post
The problem of protein aggregation and presence of extrinsic particles in biopharmaceutical formulations is not a small one. With the improvement of …
Read Post
University of Colorado PhD student, Vaida Linkuviene, along with Fluid Imaging Applications Scientist, Heather Anne Wright, and Co-Director of the …
Read Post
Proteinaceous particles in parenteral drugs pose an immunogenic risk. These formulations are therefore rigorously characterized for optimal …
Read Post
In a recent study by Kiyoshi et al., a Japanese consortium conducted a collaborative study to assess the standardization of flow imaging microscopy …
Read Post
Your current particle analyzer counts the subvisible particles in your protein therapeutic. A particle size distribution curve is generated and …
Read Post
The most common method for characterizing subvisible particles (SVP) ranging in size from 10µm to 100µm is light obscuration (LO). "LO, however, has …
Read Post
Omontys® – a brand name peginesatide injectable – was voluntarily withdrawn from the market less than a year after the product launch. Clinical …
Read Post
AB BioTechnologies, Inc. located in Bloomington, Indiana is a privately held laboratory offering pharmaceutical contract services. Founder and CEO …
Read Post